TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS: EFFICACY AND SAFETY OF CHANGEOVER

• প্রধান লেখক: A. A. Baranov (লেখক), E. I. Alexeeva (লেখক), S. I. Valieva (লেখক), T. M. Bzarova (লেখক), E. V. Mitenko (লেখক), R. V. Denisova (লেখক), A. N. Fetisova (লেখক), T. V. Sleptsova (লেখক), K. B. Isaeva (লেখক), E. G. Chistyakova (লেখক), N. I. Taibulatov (লেখক), A. M. Chomakhidze (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: "Paediatrician" Publishers LLC, 2014-01-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Aim: to assess efficacy and safety of «changeover» to the second genetically engineered biological agent (GEBA) in patients with juvenile idiopathic arthritis (JIA) with resistance or intolerability to the first GEBA. Patients and methods: the results of retrospective observational research of effic...